ValuEngine Upgrades Calyxt (NASDAQ:CLXT) to “Hold”

ValuEngine upgraded shares of Calyxt (NASDAQ:CLXT) from a sell rating to a hold rating in a report issued on Wednesday, March 14th.

Other analysts also recently issued reports about the stock. Jefferies Group reissued a buy rating and issued a $27.00 price target on shares of Calyxt in a research note on Thursday, March 1st. Zacks Investment Research raised shares of Calyxt from a sell rating to a hold rating in a research note on Tuesday, November 28th. Ladenburg Thalmann Financial Services began coverage on shares of Calyxt in a research note on Wednesday, December 20th. They set a buy rating and a $34.25 price objective for the company. Finally, Citigroup lowered their price objective on shares of Calyxt from $27.00 to $22.00 and set a neutral rating for the company in a research note on Thursday, November 16th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and an average price target of $29.05.

How to Become a New Pot Stock Millionaire

Shares of NASDAQ CLXT traded down $1.23 during mid-day trading on Wednesday, reaching $14.79. 38,907 shares of the company were exchanged, compared to its average volume of 77,414. Calyxt has a 52 week low of $9.26 and a 52 week high of $31.89. The company has a debt-to-equity ratio of 0.18, a quick ratio of 13.52 and a current ratio of 13.52. The company has a market capitalization of $449.56 and a P/E ratio of -13.21.

In other news, Director Michel Arbadji sold 3,500 shares of the company’s stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $18.63, for a total value of $65,205.00. Following the transaction, the director now owns 32,900 shares in the company, valued at $612,927. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Manoj Sahoo sold 10,780 shares of the company’s stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $19.87, for a total transaction of $214,198.60. Following the completion of the transaction, the insider now owns 95,146 shares in the company, valued at approximately $1,890,551.02. The disclosure for this sale can be found here. In the last 90 days, insiders sold 104,496 shares of company stock worth $2,045,928.

A number of institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. bought a new position in Calyxt during the fourth quarter valued at approximately $330,000. Deutsche Bank AG lifted its position in Calyxt by 151.3% during the fourth quarter. Deutsche Bank AG now owns 18,378 shares of the company’s stock valued at $404,000 after purchasing an additional 11,064 shares during the period. BlackRock Inc. lifted its position in Calyxt by 102.8% during the fourth quarter. BlackRock Inc. now owns 740,010 shares of the company’s stock valued at $16,302,000 after purchasing an additional 375,137 shares during the period. Wells Fargo & Company MN lifted its position in Calyxt by 1,421.9% during the fourth quarter. Wells Fargo & Company MN now owns 30,788 shares of the company’s stock valued at $678,000 after purchasing an additional 28,765 shares during the period. Finally, California State Teachers Retirement System bought a new position in Calyxt during the third quarter valued at approximately $323,000. Institutional investors own 22.06% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “ValuEngine Upgrades Calyxt (NASDAQ:CLXT) to “Hold”” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another website, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/07/calyxt-clxt-rating-increased-to-hold-at-valuengine.html.

About Calyxt

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply